ArticleCancer immunology, immunotherapy : CII2021

Circulating leukocyte-platelet complexes as a predictive biomarker for the development of immune-related adverse events in advanced non-small cell lung cancer patients receiving anti-PD-(L)1 blocking agents.

Carlos Zamora et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.